MIRA
INFORM REPORT
|
Report Date : |
24.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
NENTAR & CO., INC. |
|
|
|
|
Registered Office : |
Oriental Road, High-Tech
Development Zone, Jingzhou City, Hubei Province 434000 PR |
|
|
|
|
Country : |
China |
|
|
|
|
Date of Incorporation : |
31.05.2010 |
|
|
|
|
Com. Reg. No.: |
421000000074403 |
|
|
|
|
Legal Form : |
Shares Limited Co |
|
|
|
|
Line of Business : |
Engaged
in developing, researching, manufacturing & selling pharmaceutical intermediates
and chemical pharmaceuticals. |
|
|
|
|
No. of Employees : |
150 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
NENTAR
& CO., INC.
ORIENTAL ROAD, HIGH-TECH
DEVELOPMENT ZONE, JINGZHOU CITY,
HUBEI
PROVINCE 434000 PR CHINA
TEL: 86 (0) 716-8303013/8303480 FAX:
N/A
EXECUTIVE SUMMARY
INCORPORATION DATE : MAY 31, 2010
REGISTRATION NO. : 421000000074403
REGISTERED LEGAL FORM :
Shares limited co.
STAFF STRENGTH : 150
REGISTERED CAPITAL :
CNY 75,000,000
BUSINESS LINE : r&d, MANUFACTURE
TURNOVER : N/A
EQUITIES : N/A
PAYMENT : AVERAGE
RECOMM. CREDIT RANGE : MODERATE AMOUNT
MARKET CONDITION : AVERAGE
FINANCIAL CONDITION : N/A
OPERATIONAL TREND :
fairly STEADY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY 6.3532 = USD
Adopted
abbreviations:
ANS -
amount not stated
NS -
not stated
SC -
subject company (the company inquired by you)
NA - not available
CNY - China Yuan Ren Min Bi
SC was registered as a Shares limited co. at
local Administration for Industry & Commerce (AIC - The official body of
issuing and renewing business license) on May 31, 2010.
Company Status: Shares limited co. This form of business in PR
China is defined as a legal person. Its registered capital is divided into
shares of equal par value and the co. raises capital by issuing share
certificates by promotion or by public offer. Shareholders bear limited
liability to the extent of shareholding, and the co. is liable for its
debts only to the extent of its total assets. The co has independent
property of legal person and enjoys property rights of legal person. The
characteristics of the shares limited co. are as follows: The establishment of the co.
requires at least two promoters and no more than 200, half of whom shall be
domiciled in The minimum registered capital
of a co. is CNY The board of directors must
consist of five to nineteen directors. If the co. raises capital by
public offer, the promoters must not subscribe less than 35% of the total
shares. the promoters’ shares are restricted to transfer- within one year
of the offer. A state-owned enterprise that
is restructured into a shares limited co. must comply with the conditions
& requirements specified under the law & administrative rule.
SC’s
registered business scope includes developing, researching, manufacturing &
selling new pharmaceutical intermediate which are not limited by the state,
related technical services and technology transfer; developing, researching,
manufacturing & selling non-state prohibited non-polluting chemical
products; import and export business.
SC is
mainly engaged in developing, researching, manufacturing & selling
pharmaceutical intermediates and chemical pharmaceuticals.
Mr.
Chen Liequan is legal representative, chairman and general manager of SC at
present.
SC is
known to have approx. 150 employees at present.
SC is currently operating at the above stated address, and this
address houses its operating office and factory in the high-tech development
zone of Jingzhou. The detailed information of the area is unspecified.
http://www.jznengte.com The design is professional and the content is
well organized. At present it is in Chinese and English versions.
Email: sales@jznengte.com
SC's predecessor was Winchem
Pharm. and Chem. Co., Inc.
MAIN SHAREHOLDERS:
Name %
of Shareholding
Wang Quansheng
2.67
Yang Zhicheng
20.31
Zhejiang Manbo Investment Management Co., Ltd.
5
Cai Heting
15.40
Chen Liequan
25.59
Zhang Wenqi
16.92
Zhejiang Wanlun Investment Partnership (Limited Partnership)
(in Chinese pinyin)
3
Hangzhou Lianchuang Yong Yi Venture Capital Partnership
(Limited Partnership)
8
Qin Huiling
3.11
l
Legal representative, chairman and
general manager:
Mr. Chen Liequan is currently responsible for the overall
management of SC.
Working Experience(s):
At present Working in SC as legal representative,
chairman and general manager.
SC is
mainly engaged in developing, researching, manufacturing & selling
pharmaceutical intermediates and chemical pharmaceuticals.
SC’s products
mainly include: pharmaceutical intermediates and active pharmaceutical
ingredients, etc.
SC
sources its materials 80% from domestic market, and 20% from overseas market.
SC sells 70% of its products in domestic market, and 30% to the overseas market.
The buying terms of SC include Check, T/T, L/C and Credit of
30-60 days. The payment terms of SC include T/T, L/C and Credit of 30-60 days.
Note: SC’s management declined to release its main clients
and suppliers.
The information on SC’s subsidiaries is not available.
Overall payment appraisal:
( ) Excellent (
) Good (X) Average (
) Fair ( ) Poor
( ) Not yet determined
The appraisal serves as a reference to reveal SC's payments
habits and ability to pay. It is based
on the 3 weighed factors: Trade payment
experience (through current enquiry with SC's suppliers), our delinquent
payment and our debt collection record concerning SC.
Trade payment experience: SC
did not provide any name of trade/service suppliers and we have no other
sources to conduct the enquiry at present.
Delinquent payment record: None
in our database.
Debt collection record: No overdue amount owed by SC was
placed to us for collection within the last 6 years.
SC’s
management declined to release its bank details.
SC’s
financial reports were not found during our checks with the local
Administration for Industry and Commerce.
SC’s
management declined to release any financial information.
SC is considered medium-sized in its line with favorable
background. Credit up to moderate amount may be considered.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.38 |
|
|
1 |
Rs.87.79 |
|
Euro |
1 |
Rs.69.47 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.